This bill, known as the Daughters of the American Revolution Membership Integrity Act, amends federal law to explicitly limit membership in the Daughters of the American Revolution to adult human females. It defines a female as someone who naturally possesses or would have the reproductive system capable of producing ova for fertilization, regardless of any congenital anomalies or medical disruptions. By adding this specific definition to the organization's governing code, the legislation clarifies the genealogical and biological requirements for joining the group. The change directly affects the organization's eligibility rules but does not alter its internal operations or funding.
The Drug Deal Disclosure Act requires the Department of Health and Human Services to publicly release records of specific agreements between the federal government and major drug manufacturers starting in 2025. These agreements must include provisions such as offering lower drug prices based on international rates, providing discounts through government platforms like TrumpRx, or receiving special exemptions from import duties and regulatory reviews. While the bill mandates that most documents be made available in a searchable format, it allows the government to withhold only specific confidential pricing details if legally required by foreign laws or court orders, provided a justification is published. Additionally, the law directs the Congressional Budget Office and the Government Accountability Office to analyze the economic and budgetary impacts of these deals, including effects on Medicare, Medicaid, and drug competition.
The Advanced Coursework Equity Act establishes a federal grant program designed to increase access to advanced science, technology, engineering, and mathematics courses for students in under-resourced schools and historically underrepresented groups. To achieve this, the bill requires recipients to adopt either open enrollment, which allows any student to join without barriers, or universal screening, which uses objective assessments to identify qualified students rather than relying solely on subjective teacher recommendations. Funding is distributed to state and local education agencies to cover costs such as training educators on equity strategies, expanding course capacity, and providing tutoring, with a specific focus on closing achievement gaps in STEM fields. The program includes strict reporting requirements and offers bonus payments to districts that demonstrate the most significant progress in enrolling diverse students in advanced coursework over the three-year grant period.
This bill strengthens the Epstein Files Transparency Act by giving state attorneys general and victims the legal right to sue the U.S. Attorney General if they unlawfully withhold, redact, or delay access to investigation records. It requires the Justice Department to provide unredacted copies of documents to state officials for use in investigations and to victims personally, while allowing redactions only to protect the privacy of other victims. The legislation also mandates that courts expedite these cases, removes common legal excuses for hiding documents, and imposes criminal penalties on federal employees who obstruct compliance. Additionally, it grants Members of Congress the authority to request full access to records and to file lawsuits if the Attorney General fails to comply within a set timeframe.
The Patients First Act of 2026 modifies how Medicare reimburses physicians and primary care providers to improve access and stabilize payments. It establishes a new hybrid payment model for primary care services from 2027 to 2031, which pays a monthly fee per patient to eligible independent practices while covering specific services like care management and telehealth without cost-sharing for patients. The bill also updates the formula for calculating reimbursement rates to account for high inflation years and requires more frequent updates to the costs used in calculating payments. Additionally, the legislation reforms the performance-based payment system by adding care efficiency measures, creating a task force to recommend new quality metrics, and adjusting penalties for providers who fail to report on certain data.
The Medicare Advantage MLR Transparency Act requires insurance companies offering Medicare Advantage plans to publicly disclose detailed financial data starting in 2029. Under this bill, each plan must report how much total revenue it collects and specifically how much is spent on actual medical claims versus administrative overhead costs. The law also mandates that this financial information be presented in a consumer-friendly format and aligns the way benefits are displayed with standards used by other health insurance plans. These changes aim to give Medicare beneficiaries clearer insight into how their premiums are utilized by the plans they choose.
The Medicare Access to Rural Anesthesiology Act changes how Medicare pays for anesthesia services at specific small rural hospitals and critical access hospitals. To qualify for these changes, a hospital must be located in a rural area, have fewer than 800 surgeries requiring anesthesia, and employ or contract with no more than one full-time anesthesiologist who agrees not to bill Medicare separately for those services. Once a hospital meets these criteria, anesthesia care provided by an anesthesiologist there will be paid based on the hospital's actual costs rather than a fixed fee, and it will be classified as part of the hospital's inpatient services instead of a separate billable service. The law also requires the Department of Health and Human Services to update its regulations to reflect these new payment rules.
HR 7651, the Chloe Cole Act of 2026, prohibits healthcare providers from performing certain medical interventions on minors under 18 aimed at altering physical development to align with gender identity. These "covered interventions" include puberty blockers, hormone treatments, and specific surgeries, but exclude medically necessary care for conditions like disorders of sexual development or traumatic injuries. The bill creates a federal civil lawsuit right for affected minors or their parents against providers who perform such interventions, allowing claims for damages including emotional distress and punitive awards, with strict liability for providers after the law's enactment. It explicitly allows exceptions for legitimate medical treatments and requires providers to prove such exceptions apply if challenged.
HR 7184, the PRESS Act, targets equipment used to manufacture illegal drugs by making it unlawful to sell specific items like tableting machines, gelatin capsules, or related chemicals when the seller knows the equipment will be used to produce controlled substances for unlawful U.S. importation. It directly affects manufacturers and distributors of these drug-making tools who have knowledge or reasonable cause to believe their products will facilitate illegal drug trafficking. The bill adds new prohibitions to the Controlled Substances Act and increases potential prison sentences for violations, with penalties reaching up to 20 years for major offenses involving large quantities of equipment or chemicals. These changes aim to disrupt the supply chain for illicit synthetic drugs by holding equipment sellers accountable for their intended use.
HR 5880, the "Fight Illicit Pill Presses Act," requires manufacturers and distributors of pill-making machines (like tableting machines) and their critical parts (such as punches and dies) to affix permanent serial numbers to these items. It mandates that these businesses report transactions involving such machines to the Attorney General and maintain records of the serial numbers. The law prohibits tampering with or knowingly distributing machines with removed or altered serial numbers. This directly affects manufacturers, distributors, and sellers of these specific pill-production machines and parts, aiming to improve tracking of equipment used in illicit drug manufacturing.
This bill requires Medicare Advantage plans to implement electronic pre-approval systems for medical services by 2028 and meet transparency reporting standards starting in 2027. Plans must publicly report data on approval/denial rates, appeal outcomes, response times, and technology use for pre-approval requests, including details on how denials relate to clinical criteria. It establishes a 24-hour response timeframe for certain requests and mandates annual reviews of pre-approval requirements based on data and input from seniors and providers. The law directly affects Medicare Advantage plans, seniors enrolled in these plans, and healthcare providers who submit pre-approval requests. These changes aim to make the pre-approval process faster, more transparent, and more accountable for seniors seeking covered medical services.
HR 3100 amends the National Child Protection Act of 1993 to expand background check requirements. It allows businesses and organizations working with vulnerable populations (like children or elderly individuals) to request background checks for their contractors and for people they license or certify to provide care. The bill modifies the law to include individuals "contracted with" or "licensed/certified by" these organizations as those requiring background checks. This change directly affects organizations serving vulnerable groups, their contractors, and licensed care providers by broadening the scope of background checks mandated under the Act.
